We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.80 | 1.49% | 190.40 | 189.20 | 190.40 | 192.00 | 187.40 | 189.20 | 284,402 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.85 | 410.96M |
TIDMAMS
RNS Number : 7775L
Advanced Medical Solutions Grp PLC
05 October 2016
5 October 2016
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 30 September 2016 that Eddie Johnson, who is a Senior Manager and PDMR, had exercised 50,000 Ordinary Shares of 5p from the 2009 Executive Share Option Scheme and sold all 50,000 shares.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person closely associated --- ----------------------------------------------------------------- a) Name: Eddie Johnson --- ----------------------------------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- ----------------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- ----------------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- ----------------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- ----------------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- ----------------------------------------------------------------- b) Nature of the transaction: * Exercised 50,000 Ordinary Shares of 5p from the 2009 Executive Share Option Scheme; * Sale of 50,000 shares from the total shares exercised. --- ----------------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------- ---------- GBP2.289663 50,000 ------------- ---------- --- ----------------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 50,000 Aggregated price: GBP2.289663 --- ----------------------------------------------------------------- e) Date of the transaction: 30/09/2016 --- ----------------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- -----------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0) plc 1606 545508 Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott / Jonathan AMS@consilium-comms.com Birt / Matthew Neal / Hendrik Thys Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970 Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBBBDGLDGBGLU
(END) Dow Jones Newswires
October 05, 2016 07:26 ET (11:26 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions